From December 2nd to 4th, 2022, Beijing time, organized by the Dermatology and Cosmetology Branch of the Chinese Medical Equipment Association, the Psoriasis Professional Committee of the Dermatology and Venereology Branch of the Chinese Medical Association, the International Psoriasis Council (IPC) and Global Psoriasis Sponsored by the Surveillance Program (GPA); organized by the First Affiliated Hospital of Anhui Medical University and the Institute of Dermatology of Anhui Medical University, the 6th China Psoriasis Conference was held in Hefei, Anhui. Medical media platforms such as Yiwohang, Shilian Medical, CCMTV, Miaoshou, Medical World, Mays Medical, Youmai and Yixin will simultaneously broadcast live online. The theme of this conference is "Hand in Hand, Love Without Silver". The meeting invited academicians of the Chinese Academy of Sciences, academicians of the Chinese Academy of Engineering, well-known psoriasis experts and researchers at home and abroad, and representatives of dermatologists from the frontline and grassroots, focusing on "psoriasis translational medicine", "psoriasis basic and clinical research new "Progress", "New Treatment of Psoriasis" and "Psoriasis Comorbidity and Chronic Disease Management" to carry out academic exchanges and discussions.

Professor Sun Liangdan, executive chairman of the conference, presided over the opening ceremony of the conference

(1) Opening Ceremony

The opening ceremony of the conference was held on the morning of December 3, presided over by Professor Sun Liangdan, the executive chairman of the conference and the First Affiliated Hospital of Anhui Medical University. Professor Zhang Xuejun, chairman of the conference, chairman of the Psoriasis Committee of the Dermatology Branch of the Chinese Medical Association, and chairman of the Dermatology and Dermatology Cosmetology Branch of the Chinese Medical Equipment Association, delivered a welcome speech. Professor Zhang Xuejun, on behalf of the conference organizer, expressed his warmest welcome and heartfelt thanks to all the leaders, experts, friends from all walks of life and many professors from overseas who participated in this conference. Professor Zhang Xuejun pointed out that the China Psoriasis Conference has built a very good platform for academic exchanges in the field of psoriasis research and dialogue between doctors and patients, and has promoted the rapid development of disease prevention, diagnosis and treatment. Professor Zhang Xuejun also introduced the development status of psoriasis-related businesses at home and abroad, the process of formulating the "Guidelines for the Diagnosis and Treatment of Psoriasis in China" (2022 Edition) and the "Expert Consensus on the Treatment of Biological Agents for Psoriasis" and summarized the past five sessions. The successful experience and social response of the China Psoriasis Conference, and an outlook on the future development of China's psoriasis-related undertakings.

The chairman of the conference, Professor Zhang Xuejun, delivered an opening speech

At the opening ceremony, President Sun Beicheng of the First Affiliated Hospital of Anhui Medical University, the organizer of the conference, delivered a welcome speech online. Heartfelt best wishes to psoriasis patients across the country. And I hope that under the guidance of the Dermatology Branch of the Chinese Medical Association and with the joint efforts of all experts, through the establishment of the "Psoriasis Specialized Disease Demonstration Clinic" and the "Dandelion Psoriasis Patient Education Public Welfare Tour", Promote the development of psoriasis prevention, diagnosis and treatment in China, popularize health science education for psoriasis patients, and benefit millions of psoriasis patients in my country.

Dean Sun Beicheng of the First Affiliated Hospital of Anhui Medical University delivered an opening speech

Professor Lu Jinjin, chairman of the Dermatology and Venereology Branch of the Chinese Medical Association and director of the Dermatology Hospital of the Chinese Academy of Medical Sciences, also delivered an online speech. Professor Lu Jinjin, on behalf of the Dermatology Branch of the Chinese Medical Association and the organizers and organizers of the conference, expressed his sincere gratitude and warm welcome to the experts and scholars, and proposed that the conference will improve the basic research and clinical diagnosis and treatment of psoriasis in my country. have positive promotional significance.

Professor Lu Qianjin, chairman of the Dermatology and Venereology Branch of the Chinese Medical Association, delivered an opening speech

Wang Yongjin, executive deputy secretary-general of the Healthy China Research Center and vice president of the "Healthy China Watch" magazine of the National Health Commission, represented the "Healthy China Watch" magazine and the Healthy China Research Center to all the guests, doctors and companies who came to this meeting The representatives extended a warm welcome. He also called on people from all walks of life to correctly understand and treat psoriasis, hoping to promote the popularization of psoriasis prevention and control knowledge through the "Psoriasis Conference".

Wang Yongjin, deputy secretary-general of the Healthy China Research Center, delivered an opening speech

At the opening ceremony, awards were also given to units and individuals who have made outstanding contributions to psoriasis prevention and control and the Global Psoriasis Surveillance Program (GPA). After pre-declaration and selection, according to the psoriasis demonstration clinics and special disease clinic conditions, as well as the psoriasis committee's discussion and approval, a total of 10 psoriasis demonstration clinic units and 11 world psoriasis clinics were selected. The excellent free clinic unit in Japan was awarded to 35 outpatient units for psoriasis at the same time. At present, the Psoriasis Professional Committee of the Dermatology and Venereology Branch of the Chinese Medical Association has successively selected nearly 350 psoriasis outpatient clinics across the country, providing convenience for psoriasis patients to seek medical treatment.

List of licensing units

The conference also awarded the "Lifetime Achievement Award" to Professor Zhang Xibao from the Institute of Dermatology, Guangzhou Medical University, who has been committed to the basic and clinical research of psoriasis, in recognition of his outstanding contribution to the prevention, diagnosis and treatment of psoriasis in my country. At the same time, Professor Liang Yanhua from Shenzhen Hospital of Southern Medical University, Professor Yin Zhiqiang from Jiangsu Provincial People's Hospital, and Professor Liu Hong from Xiangya Hospital of Central South University were awarded the "Rising Star Award".

Winners

The open project of "Standardized Diagnosis and Treatment of Psoriasis and Chronic Disease Management Research" of the Key Laboratory of Dermatology Ministry of Education was also released at the opening ceremony. The press conference was hosted by Professor Wang Zaixing, the executive chairman of the conference and director of the Department of Dermatology of the First Affiliated Hospital of Anhui Medical University host. Professor Wang Zaixing pointed out that the establishment of the open project aims to use the platform of the Key Laboratory of Dermatology Ministry of Education to promote clinical research and standardized diagnosis and treatment of inflammatory skin diseases such as psoriasis, and introduced the application guidelines for the open project in detail.

Professor Wang Zaixing, executive chairman of the conference, presided over the open project of the Key Laboratory of Dermatology, Ministry of Education

(2) Psoriasis Translational Medicine Forum Session

As one of the highlights of this conference, the "Psoriasis Translational Medicine Forum" was held after the opening ceremony on the morning of December 3. Professor Zhang Furen from Shandong First Medical University, Professor Zheng Jie from Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Professor Wang Gang from Xijing Dermatology Hospital of Fourth Military Medical University and Professor Cui Yong from China-Japan Friendship Hospital co-hosted the event.

Moderator of Translational Medicine Forum

Academician Wei Yuquan of the Chinese Academy of Sciences (West China Hospital, Sichuan University) delivered a keynote report entitled "Research Progress in Biological Therapy", introduced the current basic situation of global biological treatment, explained the mechanism of biological treatment of tumors and other diseases, and introduced himself A variety of gene therapy products developed by the team are not only for the treatment of tumors, but also for biological agents related to skin diseases such as epidermolysis bullosa. Zhao Guoping, academician of the Chinese Academy of Sciences (School of Life Sciences, Fudan University), gave a keynote speech on "Human Genome Project and GWAS". It has expanded to the research fields of plants and microorganisms. At the same time, the continuously updated human GWAS chip, the human phenome project and phenotype-related analysis expanded from GWAS research, and clinical multi-omics-related research and analysis will continue to serve the people's health. Academician Chen Runsheng of the Chinese Academy of Sciences (Institute of Biophysics, Chinese Academy of Sciences) gave a wonderful speech entitled "Precision Medicine, Artificial Intelligence and Nucleic Acid Drugs". Academician Chen pointed out that the key to accurate data lies in the collection and integration of molecular omics, the characterization and quantification of phenomics, and the coupling of micro and macro. He introduced the relationship between artificial intelligence, medical care, and genome, and listed Research progress of the new crown vaccine. Academician Tian Zhigang of the Chinese Academy of Engineering (University of Science and Technology of China) gave a speech entitled "Synthetic Immunology and NK Cell Therapy". Academician Tian believes that NK cells have the potential and advantages of becoming the next generation of cellular immunotherapy after T and B cells. In particular, two important events in 2020 will sound the charge of NK cell immunotherapy.

Academician teaching

Professor James T Elder from the University of Michigan delivered a speech entitled "Pinpointing Genes for Psoriasis and Psoriatic Arthritis". Professor James T Elder first introduced the discovery of psoriasis susceptibility genes, which confirmed that psoriasis is an immune-related disease and provided targets for psoriasis immunotherapy; then introduced the role of human histocompatibility complex in the pathogenesis of psoriasis important role; and finally emphasize the role of functional genomics in elucidating the regulatory function of psoriasis susceptibility loci in order to define pathogenic loci. Professor Zhang Xuejun from the First Affiliated Hospital of Anhui Medical University gave a report entitled "China's Contribution to Psoriasis Translational Medicine". Professor Zhang Xuejun began to explain the outstanding contributions of Chinese people in psoriasis epidemiology, basic research and clinical transformation from the domestic psoriasis research results. Introduced the team's psoriasis genetics research and found that the skin barrier genes LCE, IL-23 and IL-17 signaling pathways play a vital role in the pathogenesis of psoriasis, which has become the basis for the development of targeted drugs such as biologics monoclonal antibodies . Professor Zhang Xuejun also emphasized the current situation of psoriasis biologics contention, and put forward the suggestion of "Based on the standard, the whole process of management - the whole process of psoriasis standardized management".

Prof. James T Elder and Prof. Zhang Xuejun giving lectures

(3) Special forum on new treatments for psoriasis

On the afternoon of December 3, 2022, the 6th China Psoriasis Conference set up an online cloud venue for the "New Psoriasis Treatment Special Session", which was highly praised by all participants. Experts at home and abroad from biological agents, small Molecular targeted drugs and the integration of traditional Chinese and Western medicine introduced the latest research progress in the treatment of psoriasis.

Professor Shi Yuling from Shanghai Dermatology Hospital, Professor Kang Xiaojing from Xinjiang Uygur Autonomous Region People's Hospital, Professor Wang Peiguang from the First Affiliated Hospital of Anhui Medical University, Professor Li Yuzhen from the Second Affiliated Hospital of Harbin Medical University, and Liu Tao from the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine Professor Feng co-hosted.

Moderator of the Special Forum on New Treatment of Psoriasis

Professor April Armstrong from the University of Southern California first shared "Biologic Treatments for Psoriasis Patients: a Focus on IL-17 Inhibitors", combined with real world data (Real World Data, RWD) on the treatment of biological agents for psoriasis, especially IL-17 The application of -7 inhibitors was explained, with special emphasis on the long-term efficacy and safety of biological agents; Professor Zhang Xibao from the Institute of Dermatology of Guangzhou Medical University brought "the application and research progress of small molecule targeted drugs in psoriasis" , mainly introduced the efficacy and safety of JAK inhibitors, PDE-4 inhibitors and other small molecule targeted drugs in the treatment of psoriasis. Professor Bai Yanping from Beijing China-Japan Friendship Hospital shared "Clinical Experience in Treating Psoriasis with Traditional Chinese Medicine", which involved the etiology mechanism of psoriasis, syndrome differentiation and treatment, and guidelines for psoriasis treatment, and shared her own clinical experience in the treatment of psoriasis ;Professor Li Hongyi from Guangdong Provincial Hospital of Traditional Chinese Medicine brought "Thinking of Chinese Medicine in the Era of Biological Agents for Psoriasis", compared the advantages and disadvantages of biological agents and traditional Chinese medicine in the treatment of psoriasis, and said "What can Chinese medicine do in the era of biological agents?" What" question was introduced in detail.

Prof. April Armstrong, Prof. Zhang Xibao, Prof. Bai Yanping and Prof. Li Hongyi

Professor Zhou Xiaoyong from Wuhan First Hospital shared "Moss-like reaction induced by IL-17 inhibitors?" Through clinical case presentations, he discussed the follow-up response of IL-17 inhibitors to the human immune network, and pointed out that in the clinical selection of biological When making preparations, attention should still be paid to the possible differential diagnosis of the target; Professor Chen Jinguang from Taizhou Central Hospital in Zhejiang Province brought "Psoriasis Immunotherapy Progress" and introduced the research progress of immunotherapy at home and abroad, including neutrophils, tissue The role of resident T cells and innate lymphocytes in the pathogenesis of psoriasis, and pointed out that skin immunotherapy has opened a new era. Professor Shi Yuling from Shanghai Dermatology Hospital shared "the application value of sequential therapy in the treatment of psoriasis", introduced the characteristics and disease burden of psoriasis, and emphasized the importance of sequential therapy in the treatment of psoriasis Application value; Professor Yin Zhiqiang from Jiangsu Provincial People's Hospital brought a report on "Interpretation of the Key Subgroup Analysis Results of the Effisayil-1 Study--Effectiveness and Safety of IL-36 Receptor Inhibitors in GPP Attacks in Asian Populations". Data from Asian populations were found to further support the potential value of IL-36 receptor inhibitors in the treatment of acute exacerbations of generalized pustular psoriasis (GPP) in Asian psoriasis patients.

Prof. Zhou Xiaoyong, Prof. Chen Jinguang, Prof. Shi Yuling and Prof. Yin Zhiqiang

Professor Zhang Chunlei from Peking University Third Hospital shared "The Past and Present of Biological Therapy for Psoriasis", introduced the change of biological agents for psoriasis in the era of PASI75 and PASI90/100, and pointed out that psoriasis ushered in targeted and precise biological therapy era, and put forward new treatment concepts-standard treatment, disease transformation and step-down treatment; Professor Su Zhonglan from Jiangsu Provincial People's Hospital discussed "Eczema in the Treatment of Psoriasis Biological Agents", combined with clinical examples, on the relationship between psoriasis and The characteristics of AD disease, the coexistence of psoriasis and AD, the immune drift during the treatment of psoriasis and AD, and the treatment options after immune drift were explained in detail. Professor Liu Hongxia from the Hospital of Traditional Chinese Medicine Affiliated to Xinjiang Medical University shared "the era of biological agents, the exploration of the integration of Chinese and Western medicine", combined with the respective advantages of biological agents and traditional Chinese medicine treatment in the management of psoriasis, put forward the necessity of the integration of Chinese and Western medicine, and in the traditional Chinese medicine and biological The joint application of preparations was explored and summarized; Professor Zhang Zhenghua from Huashan Hospital Affiliated to Fudan University discussed the "individualized reduction strategy for biologics", through case presentations combined with individual factors that affect psoriasis biologics reduction and compliance, pointed out At present, there is still a lack of prediction of the target reduction of biologics treatment. Professor Yin Zhiqiang from Jiangsu Provincial People's Hospital shared "New Attempts to Treat Psoriasis in Special Parts", introducing palmoplantar pustular psoriasis (palmoplantar pustulosis), inverse psoriasis and arthropathic psoriasis respectively. Psoriasis treatment experience; Professor Han Ling from Huashan Hospital Affiliated to Fudan University discussed the "real-world application and experience of biological agents for psoriasis", from the comparison of the efficacy of biological agents in the real world with randomized controlled trials, drug retention rate and biological The real-world safety of preparations and other aspects are carried out one by one.

Prof. Zhang Chunlei, Prof. Su Zhonglan, Prof. Liu Hongxia, Prof. Zhang Zhenghua, Prof. Yin Zhiqiang and Prof. Han Ling

The experts who taught the lectures shared their clinical experience with the audience online, focusing on various clinical problems that may arise in the treatment of psoriasis, the mechanism of drug action, the type of clinical application, and standardized treatment. Past clinical application, so that the participants benefited a lot.

(4) New progress in basic and clinical research of psoriasis

On the afternoon of December 3rd and the morning of December 4th, 2022, the session on "New Progress in Basic and Clinical Research on Psoriasis" will continue at Anhui Hotel. A number of well-known dermatology experts and scholars at home and abroad brought wonderful speeches on the new progress of psoriasis basic research and clinical diagnosis and treatment. This forum focuses on the frontier, based on the basics, close to the clinic, and covers a wide range of topics, including basic research, clinical research, skin barrier repair of psoriasis, traditional Chinese medicine treatment of psoriasis, reasonable selection of biological agents and other aspects.

The session was hosted by Professor Xu Jinhua from Huashan Hospital Affiliated to Fudan University, Professor Zheng Min from the Second Affiliated Hospital of Zhejiang University School of Medicine, Professor Shen Zhu from Guangdong Provincial People's Hospital, Professor Gu Heng from Dermatology Hospital of Chinese Academy of Medical Sciences, and Professor Jin Zhehu from the Affiliated Hospital of Yanbian University School of Medicine , Professor Zhang Xuejun, Professor Yang Sen, Professor Wang Zaixing, Professor Xiao Fengli, and Professor Liu Shengxiu from the First Affiliated Hospital of Anhui Medical University co-hosted.  

Moderator of the session on new progress in psoriasis basic and clinical research

On the afternoon of December 3rd, Professor Zheng Min from the Second Affiliated Hospital of Zhejiang University School of Medicine shared "The Role of Disease Modification in Psoriasis in Clinical Research", pointing out that active intervention in the early stage of psoriasis and early use of Skukiyu monotherapy Anti-inhibition of IL-17A can play a key role in achieving disease modification, effectively improving the long-term course and prognosis of psoriasis, and reducing the risk of progression of psoriasis complications. Professor Chen Xiang from Xiangya School of Medicine, Central South University brought "Scientific Research on Psoriasis Based on Clinical Problems", and introduced the research on psoriasis comorbidities carried out by his research team, the new model for intelligent assessment of psoriasis severity, A new method of stem cell therapy for psoriasis and a series of research results. Professor Zheng Yan from the First Affiliated Hospital of Xi'an Jiaotong University shared "The Study of FOXE1 Regulating Keratinocytes Participating in the Pathogenesis of Psoriasis". His research found that FOXE1 is up-regulated in psoriasis, which can regulate the proliferation and inflammation of keratinocytes The expression of the factor and its function through the downstream target Wnt5a. Professor Chen Min from the Institute of Dermatology, Chinese Academy of Medical Sciences reported on "Psoriasis Relapse Mechanism and Treatment Research Progress", pointing out that memory T cells, keratinocytes, and fibroblasts are all involved in the recurrence of psoriasis, internal and external environmental factors and metabolic factors. Diseases, etc. are related to the recurrence of psoriasis, and IL-17A inhibitors can effectively control the recurrence of psoriasis.

Prof. Zheng Min, Prof. Chen Xiang, Prof. Zheng Yan and Prof. Chen Min

Professor Wang Hongmei from the Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine brought "Research on the Regulation of Inflammation-Related Transcription Factors in Keratinocytes of Psoriasis Vulgaris", and found that IL-17A, NF- The expression levels of marker proteins related to the kB signaling pathway were significantly increased, and finally it was proposed that IL-17 participates in the pathogenesis of psoriasis by activating the NF-kB signaling pathway in keratinocytes. Professor Lu Yonghong from the Second People's Hospital of Chengdu interpreted the "Report on the Current Situation and Cognition of Skin Barrier Repair in Chinese Patients with Psoriasis", and found that most patients would actively use emollients, and affirmed that emollients can improve skin dryness, Itching, but there are still problems such as low amount of emollients used, low frequency, and inappropriate usage. Doctors need to strengthen popular science education for patients to help patients improve their skin condition. Professor Sun Liangdan from the First Affiliated Hospital of Anhui Medical University shared his experience of "surmounting the difficulties and long-term "consultation"—the clinical benefits of psoriasis in the refractory part of the consultation from AAD", introducing the impact of refractory psoriasis on the lives of patients A series of clinical studies have confirmed that ixekizumab can significantly improve the clinical symptoms of refractory psoriasis and improve the quality of life of patients. Professor Jin Hongzhong from Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences talked about "the research on the role of Wnt signaling pathway and neutrophils in the pathogenesis of psoriasis", and found that the Wnt signaling pathway plays an important role in the pathogenesis of psoriasis.

Prof. Wang Hongmei, Prof. Lu Yonghong, Prof. Sun Liangdan and Prof. Jin Hongzhong

Professor Wang Honglin from the First People's Hospital Affiliated to Shanghai Jiaotong University shared the "Neuroimmunological Mechanism of Psoriasis", and introduced his research team's research on why psoriasis relapses after drug withdrawal and how to solve the two major problems of psoriasis recurrence scientific research. Professor Lu Yan from Jiangsu Provincial People's Hospital brought "Pay attention to the heterogeneity of psoriasis", emphasizing the importance of understanding the heterogeneity of psoriasis for individualized treatment, and pointed out that the differentiated treatment of different types of psoriasis is important Essentials of chronic disease management in psoriasis. Professor Sun Liangdan from the First Affiliated Hospital of Anhui Medical University brought "The Mechanism and Research Progress of TYK2 Kinase as a New Target for the Treatment of Psoriasis", introducing the basic principles of TYK2/JAK kinase inhibitors in the treatment of psoriasis and the new clinical research and development of related preparations. progress. Professor Bai Bingxue from the Second Affiliated Hospital of Harbin Medical University talked about the "Inflammation March of Psoriasis and Atopic Dermatitis", pointing out that psoriasis and atopic dermatitis have different immune mechanisms, clinical phenotypes and autoimmune comorbidities. However, there are differences in the immune microenvironment of epithelial cells between the two, so individualized treatment is very necessary.

Prof. Wang Honglin, Prof. Lu Yan, Prof. Sun Liangdan and Prof. Bai Bingxue

Professor Zhu Wu from Xiangya Hospital Affiliated to Central South University brought "RIPK1 and its inhibitors regulate the mechanism of psoriasis outcome by affecting the maturation of DCs". The maturation of dendritic cells is involved in the pathogenesis of psoriasis. The new inhibitor of RIPK1 can effectively inhibit the activity of RIPK1 kinase, down-regulate the maturation of dendritic cells and improve the inflammation of psoriasis. Professor Zhang Xiaoguang from the Second Hospital of Hebei Medical University shared the "novelty in the diagnosis and treatment of psoriasis", combined with clinical case analysis, emphasized the importance of individualized treatment and follow-up of psoriasis, and called on clinicians to treat psoriasis patients Pay attention to observation and thinking, and give patients more compassionate understanding.

Professor Zhu Wu, Professor Zhang Xiaoguang

On the morning of December 4th, the exciting content of the special session will continue. Professor Bruce Strober from Yale University School of Medicine shared "IL-23 Imhibition For the Treatment of Psoriasis", introducing the mechanism of action and clinical diagnosis and treatment progress of current biological agents targeting IL-23 for the treatment of psoriasis.

Professor Bruce Strober

Professor Ji Chao from the First Affiliated Hospital of Fujian Medical University brought "Diagnosis and Treatment Progress of Generalized Pustular Psoriasis" and gave a detailed overview of the concept, pathogenesis and progress of diagnosis and treatment of GPP in pustular psoriasis ;Professor Su Yin from Peking University People's Hospital shared "Renewal of Early Identification and Management of Psoriatic Arthritis". The predicted indicators further improve the level of diagnosis and treatment of psoriatic arthritis; Professor Zhao Yi from Beijing Tsinghua Changgung Hospital shared the "Research on Individualized Programs of Psoriasis Biological Agents Treatment", pointing out that in real-world research, it is necessary to conduct research based on the needs of patients. Individualized treatment, taking into account the curative effect and economic cost, and conducting standardized exploration; Professor Liu Na from Shanghai Sixth People's Hospital brought "The role of γδT cells in the recurrence of psoriasis", pointing out that the mechanism of γδT cells in the recurrence of psoriasis is mainly Plays an important role by migrating to the inflammatory part, and through CCR6 on the surface. Professor Sun Liangdan from the First Affiliated Hospital of Anhui Medical University shared "Traveling Changes to Achieve - A Preliminary Exploration of the Targets of Psoriasis Comprehensive Treatment from Single to Comprehensive", introducing that psoriasis is a systemic disease, and the treatment needs to achieve long-term cleansing, long-term safety, The goal of freedom and release; Professor Geng Songmei from the Second Affiliated Hospital of Xi'an Jiaotong University shared "Xinbike Opens a New Model of External Medicine Stage Treatment", pointing out that the drug has the characteristics of significant curative effect, long remission period and high safety.

Prof. Ji Chao, Prof. Su Yin, Prof. Zhao Yi, Prof. Liu Na, Prof. Sun Liangdan and Prof. Geng Songmei

Professor Lu Chengzhi from Dalian Dermatology Hospital talked about the "construction and management of biological preparations treatment center", and introduced the construction process and management experience of the biological preparations center using Dalian Dermatology Hospital as a template; Professor Ding Yangfeng from Shanghai Dermatology Hospital shared "Safety thinking and coping strategies for long-term application of biological agents", pointing out that compared with traditional treatment, there is still less experience in the use of biological agents, safety issues are the first consideration and side effects of treatment should be paid attention to; Central South University Xiangya Professor Liu Hong from the hospital brought "The Role of Metabolism in Skin Diseases", introduced the manifestations of metabolic abnormalities in psoriasis, urticaria, and melanoma, and carried out corresponding translational research on the research results; the prevention and treatment of skin diseases in Guangzhou Professor Zhang Sanquan from the Institute talked about "Treatment and Management of Psoriasis Complicated with Obesity", pointing out that obesity is closely related to the onset of psoriasis, and explored the use of secukinumab for obese patients with psoriasis; Anhui Medical University Professor Tang Huayang from the First Affiliated Hospital brought "Psoriasis Single Cell and Spatial Transcriptome Sequencing Research".

Prof. Lv Chengzhi, Prof. Ding Yangfeng, Prof. Liu Hong, Prof. Zhang Sanquan, Prof. Tang Huayang gave lectures

Many experts at this conference focused on the basic research and clinical diagnosis and treatment of psoriasis, from basic to clinical, from traditional drugs to the latest biological agents, small molecule drugs, and treatment methods, focusing on various clinical problems and drugs in the treatment of psoriasis. In terms of mechanism of action, clinical applicable types, standardized treatment, etc., each speaker starts from a different angle and comprehensively interprets the latest research progress of psoriasis. The level of diagnosis and treatment of psoriasis has played a positive role in promoting the development of psoriasis prevention and treatment in my country.

After the two-and-a-half-day meeting completed the scheduled schedule, the closing ceremony of the conference was hosted by Professor Wang Zaixing, the executive chairman of the conference, at noon on December 4. First of all, I would like to thank all the leaders and experts for their support, and express my gratitude to the organizers, co-organizers and support units. He expressed his gratitude and pointed out that this conference invited top experts and scholars in the field of psoriasis at home and abroad to give a series of lectures on the etiology, pathogenesis, diagnosis and treatment of psoriasis, and share clinical experience. , High-quality conference, according to statistics, the online live broadcast has more than 1 million clicks to watch. The successful convening of the conference is of great significance to further promote the rapid development of my country's psoriasis basic scientific research and clinical prevention, diagnosis and treatment.

Conference photo